Delivery Order SPE2DB22D2206-SPE2DB24FHV90

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,735.67, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of ABILIFY MAINTENA ER 300 MG VLS, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $9,356.16 to provide ABILIFY MAINTENA ER 400 MG VLS medical products. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,860.07 firm-fixed-price delivery order is for the supply of ABILIFY MAINTENA ER 400 MG VLS, a medication used for mental health treatment. The contract has an ultimate completion date of December 15, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,525.67 Delivery Order contract is for the supply of ABILIFY MAINTENA ER 400 MG VLS, a prescription medication. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,203.64, is for the delivery of ABILIFY MAINTENA ER 400 MG VLS, a mental health treatment medication. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ABILIFY MAINTENA ER 400 MG SYRS, a specialty pharmaceutical product. The contract has a ceiling value of $23,709.13 and an ultimate completion date of August 5, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated....
This federal contract award, valued at $3,160.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the pharmaceutical product ABILIFY MAINTENA ER 400 MG VLS, with a performance period ending on May 31, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $5,006.11, was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of ABILIFY MAINTENA ER 400 MG SYRS, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,774.10, is for the provision of ABILIFY MAINTENA ER 400 MG SYRS, a specialty medication. The contract has an ultimate completion date of October 2, 2023 and is a firm fixed-price delivery order. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $23,420.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, is a Delivery Order with a Firm Fixed Price pricing type. It covers the procurement of ABILIFY MAINTENA ER 400 MG SYRS, a medication for mental health treatment, with an ultimate completion date of December 23, 2024. Amerisourcebergen Drug...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FHV90
    Delivery Order

This federal contract award, valued at $2,020.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026.

The contract is for the delivery of ABILIFY MAINTENA ER 300 MG SYRS, a pharmaceutical product. There is no set-aside designation, indicating open competition. The contract has a final completion date of June 21, 2024. AmerisourceBergen, as the prime contractor, will be responsible for providing the required pharmaceutical products to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions served by the DLA.

Generated 5/17/25, 10:02 AM